Speech Title: Value-Based Healthcare – Can We Afford A Cure?
Biography: Omar, who holds a qualification in hospital pharmacy, has been employed for more than 15 years as the formulary advisor for Surrey & Sussex Healthcare NHS Trust. He also serves on the CCG/Commissioning Prescribing Clinical Network and the regional Joint Drugs & Therapeutics Committee.
Omar has over 30 publications to his credit and has served as a visiting lecturer at the UCLH Pharmacy Program in addition to serving as an examiner and lecturer on the University of Surrey’s Independent Prescribing V300 Course. In addition to serving as an editorial content adviser for Guidelines and a visiting lecturer on value-based pricing and innovative contracting at the University of Portsmouth, he was recently invited to accept an associate editorship in the Canadian Journal of Population Therapeutics & Clinical Pharmacology.
After serving on NICE’s External Reference Group on Cost Impact Modeling for six years, Omar was named a Panel Member for the organization’s recently established Adoption & Impact Program Reference. Presented by the UK Department of Trade & Industry, he counsels foreign investors (US Embassy) on “Value Based Assessments.” Most recently, he conducted a Healthcare NHS Reform program for more than forty US-based Healthcare Insurance Provider delegates.
He was asked to speak to the Italian Senate of Health [Senato della Repubblica] last year on Pharmacoeconomic Evaluation & Sustainability Models of Healthcare. He also gave a keynote address at the Westminster Health Forum Keynote Seminars on the Future of Pharmacy Commissionin Organization, and Delivery, which were chaired by Lord Howe of the All Party Parliamentary Group on Pharmacy.
He is now pursuing a PhD, and the topic of his thesis is “Value Based Pricing & Outcomes Based, Innovative Contracting of New Medicines.”